Syntho Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 1.50 Cr
as on 19-12-2024
- Paid Up Capital ₹ 1.21 Cr
as on 19-12-2024
- Company Age 49 Year, 7 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 0.20 M
as on 19-12-2024
- Revenue 28.97%
(FY 2022)
- Profit 76.11%
(FY 2022)
- Ebitda 20.71%
(FY 2022)
- Net Worth 32.80%
(FY 2022)
- Total Assets -7.49%
(FY 2022)
About Syntho Pharmaceuticals
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.50 Cr and a paid-up capital of Rs 1.21 Cr.
The company currently has active open charges totaling ₹0.20 M.
Dinesh Agarwal and Ekta Agarwal serve as directors at the Company.
- CIN/LLPIN
U85110UP1975PTC004139
- Company No.
004139
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
03 Jun 1975
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Kanpur
Industry
Company Details
- Location
Lucknow, Uttar Pradesh, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Syntho Pharmaceuticals Private Limited offer?
Syntho Pharmaceuticals Private Limited offers a wide range of products and services, including Common Disease Medicines, Pharmaceutical Medicine, Eye Drops, Eye Care Medicines, Carboxymethylcellulose Sodium Eye Drops, Herbal Eye Drops, Tobramycin Eye Drop, Moxifloxacin Eye Drop, Graphic Design Services, Animation Services.
Who are the key members and board of directors at Syntho Pharmaceuticals?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Dinesh Agarwal  | Managing Director | 03-Jun-1975 | Current |
Board Members(1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Ekta Agarwal | Director | 14-Dec-2009 | Current |
Financial Performance of Syntho Pharmaceuticals.
Syntho Pharmaceuticals Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 28.97% increase. The company also saw a substantial improvement in profitability, with a 76.11% increase in profit. The company's net worth Soared by an impressive increase of 32.8%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Syntho Pharmaceuticals?
Unlock access to Syntho Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Bank Of India Creation Date: 30 Jun 1992 | ₹0.10 M | Open |
Bank Of India Creation Date: 27 Dec 1978 | ₹0.10 M | Open |
How Many Employees Work at Syntho Pharmaceuticals?
Syntho Pharmaceuticals has a workforce of 42 employees as of Mar 28, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Syntho Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Syntho Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
